VentriPoint Diagnostics Ltd. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported net loss was CAD 1.35 million compared to CAD 0.612321 million a year ago. Basic loss per share from continuing operations was CAD 0.01.
For the six months, sales was CAD 0.0246 million. Net loss was CAD 2.36 million compared to CAD 2.05 million a year ago. Basic loss per share from continuing operations was CAD 0.02 compared to CAD 0.02 a year ago.